Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Carcinogenesis
|
May 31, 2014
Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids
Bhaskar Kahali, Stefanie B Marquez, Kenneth W Thompson, et al.
Cancer Research
|
February 1, 2018
HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance
Shou Liu, Ji Shin Lee, Chunfa Jie, et al.
Disaster Medicine and Public Health Preparedness
|
March 22, 2021
Telemedicine Use in Disasters: A Scoping Review
Mark Litvak, Katherine Miller, Tehnaz Boyle, et al.
Human Pathology
|
July 19, 2014
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma
Martin J Edelman, Josephine Feliciano, Binbin Yue, et al.
Oncotarget
|
February 27, 2016
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth
Yogin Patel, Nirav Shah, Ji Shin Lee, et al.
Cancer Research
|
December 28, 2014
HOXB7 promotes malignant progression by activating the TGFβ signaling pathway
Shou Liu, Kideok Jin, Yvonne Hui, et al.
Plos Medicine
|
March 29, 2007
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer
Romulo M Brena, Carl Morrison, Sandya Liyanarachchi, et al.
Cell Reports
|
June 14, 2016
MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition
Huacheng Luo, Anitha K Shenoy, Xuehui Li, et al.
International Journal of Cancer
|
August 4, 2016
BRM polymorphisms, pancreatic cancer risk and survival
Maja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, et al.
Molecular Carcinogenesis
|
September 12, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma
Ivan Pasic, Kit M Wong, Jonghun J Lee, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Carcinogenesis
|
May 31, 2014
Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids
Bhaskar Kahali, Stefanie B Marquez, Kenneth W Thompson, et al.
Cancer Research
|
February 1, 2018
HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance
Shou Liu, Ji Shin Lee, Chunfa Jie, et al.
Disaster Medicine and Public Health Preparedness
|
March 22, 2021
Telemedicine Use in Disasters: A Scoping Review
Mark Litvak, Katherine Miller, Tehnaz Boyle, et al.
Human Pathology
|
July 19, 2014
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma
Martin J Edelman, Josephine Feliciano, Binbin Yue, et al.
Oncotarget
|
February 27, 2016
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth
Yogin Patel, Nirav Shah, Ji Shin Lee, et al.
Cancer Research
|
December 28, 2014
HOXB7 promotes malignant progression by activating the TGFβ signaling pathway
Shou Liu, Kideok Jin, Yvonne Hui, et al.
Plos Medicine
|
March 29, 2007
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer
Romulo M Brena, Carl Morrison, Sandya Liyanarachchi, et al.
Cell Reports
|
June 14, 2016
MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition
Huacheng Luo, Anitha K Shenoy, Xuehui Li, et al.
International Journal of Cancer
|
August 4, 2016
BRM polymorphisms, pancreatic cancer risk and survival
Maja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, et al.
Molecular Carcinogenesis
|
September 12, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma
Ivan Pasic, Kit M Wong, Jonghun J Lee, et al.
Page
of 5